UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
Climb Bio (Nasdaq: CLYM), a clinical-stage biotechnology company focused on immune-mediated disease therapeutics, has announced its participation in four major investor conferences in September 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Climb Bio (Nasdaq: CLYM), a clinical-stage biotechnology company focused on immune-mediated disease therapeutics, has announced its participation in four major investor conferences in September 2025.
The company will participate in the Cantor Global Healthcare Conference (Sept 5), Baird Global Healthcare Conference (Sept 9), Morgan Stanley Annual Global Healthcare Conference (Sept 10), and Stifel Virtual Immunology and Inflammation Forum (Sept 16). Most events will feature fireside chats or presentations along with one-on-one investor meetings.
Live webcasts will be available through Climb Bio's investor relations website, with replays accessible for 30 days after each event.
Details
News Market Reaction – CLYM
On Aug 25, the day this news came out, CLYM closed 4.20% above the previous close.
Data tracked by StockTitan Argus for the Aug 25 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conferences detailed below.
Cantor Global Healthcare Conference
Location: New York, NY
Format: Fireside chat and one-on-one investor meetings
Date: Friday, September 5, 2025
Time: 10:55 a.m. ET
Baird Global Healthcare Conference
Location: New York, NY
Format: Fireside chat and one-on-one investor meetings
Date: Tuesday, September 9, 2025
Time: 4:20 PM p.m. ET
Morgan Stanley Annual Global Healthcare Conference
Location: New York, NY
Format: One-on-one meetings only
Date: Wednesday, September 10, 2025
Stifel Virtual Immunology and Inflammation Forum
Location: Virtual
Format: Presentation and one-on-one investor meetings
Date: Tuesday, September 16, 2025
Time: 10:30 a.m. ET
The live webcasts will be accessible via the “Investors and News” section of the Climb Bio website: https://ir.climbbio.com/. Webcast replays will be available on the Climb Bio website beginning approximately two hours after each webcast event and will be archived for at least 30 days.
About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit climbbio.com.
Investors and Media
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.